You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

DICUMAROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dicumarol, and when can generic versions of Dicumarol launch?

Dicumarol is a drug marketed by Lilly and Abbvie and is included in two NDAs.

The generic ingredient in DICUMAROL is dicumarol. There is one drug master file entry for this compound. Additional details are available on the dicumarol profile page.

Drug patent expirations by year for DICUMAROL
Recent Clinical Trials for DICUMAROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of BolognaPhase 4

See all DICUMAROL clinical trials

Medical Subject Heading (MeSH) Categories for DICUMAROL

US Patents and Regulatory Information for DICUMAROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DICUMAROL dicumarol CAPSULE;ORAL 005509-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie DICUMAROL dicumarol TABLET;ORAL 005545-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lilly DICUMAROL dicumarol CAPSULE;ORAL 005509-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.